Search Results - C. Buske

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    PB2081: TREATMENT PERSISTENCE AND ADHERENCE TO IBRUTINIB IN PATIENTS WITH WALDENSTRÖM MACROGLOBULINEMIA: A GERMAN CLAIMS DATA ANALYSIS by C. Buske, G. Hess, N. Bahar, K. Yang, B. Tang, A. Imhof, K. Vinz, E. Herweijer, M. Herold

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  2. 2

    S206: OBINUTUZUMAB PLUS CHEMOTHERAPY DEMONSTRATES LONG-TERM BENEFIT OVER RITUXIMAB PLUS CHEMOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA: FINAL ANALYSIS OF TH... by W. Townsend, W. Hiddemann, C. Buske, G. Cartron, D. Cunningham, M. J. Dyer, J. Gribben, E. Phillips, M. Dreyling, J. F. Seymour, A. Grigg, T.-Y. Lin, X.-N. Hong, D. Kingbiel, T. G. Nielsen, A. Knapp, M. Herold, R. Marcus

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  3. 3

    P1161: ASPEN: LONG-TERM FOLLOW-UP RESULTS OF A PHASE 3 RANDOMIZED TRIAL OF ZANUBRUTINIB (ZANU) VS IBRUTINIB (IBR) IN PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM) by M. Dimopoulos, S. Opat, S. D’Sa, W. Jurczak, H.-P. Lee, G. Cull, R. G. Owen, P. Marlton, B. E. Wahlin, R. Garcia-Sanz, H. McCarthy, S. Mulligan, A. Tedeschi, J. J. Castillo, J. Czyz, C. Fernandez De Larrea Rodriguez, D. Belada, E. Libby, J. Matous, M. Motta, T. Siddiqi, M. Tani, M. Trneny, M. Minnema, C. Buske, V. Leblond, S. P. Treon, J. Trotman, W. Y. Chan, J. Schneider, H. Allewelt, A. Cohen, J. Huang, C. S. Tam

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


Search Tools: